cardiab.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Cardiovascular Diabetology
official impact factor 3.35
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Cardiovascular Diabetology

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Archive
  • Article collections

Page 2 of 4

 Previous 1 2 3 4  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

26.

12226
Accesses

Review   Open Access Highly Accessed

Postprandial hyperglycemia as an etiological factor in vascular failure

Koichi Node, Teruo Inoue Cardiovascular Diabetology 2009, 8:23 (29 April 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

27.

11826
Accesses

Methodology   Open Access Highly Accessed

Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes

Maria Kompoti, Anargiros Mariolis, Alevizos Alevizos, Ioannis Kyriazis, Ioannis Protopsaltis, Eleni Dimou, Ioannis Lentzas, Dimitrios Levisianou, Afroditi Gova, Andreas Melidonis Cardiovascular Diabetology 2006, 5:21 (4 October 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

28.

11609
Accesses

Review   Open Access Highly Accessed

Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review

Peter Bramlage, Joerg Hasford Cardiovascular Diabetology 2009, 8:18 (27 March 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

29.

11098
Accesses

Original investigation   Open Access

Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus

Jonathan McGavock, Sandra Mandic, Richard Lewanczuk, Matthew Koller, Isabelle Muhll, Arthur Quinney, Dylan Taylor, Robert Welsh, Mark Haykowsky Cardiovascular Diabetology 2004, 3:3 (15 March 2004)

Abstract | Full text | PDF | PubMed

30.

10994
Accesses

Original investigation   Open Access Highly Accessed

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

Ulrich Kintscher, Peter Bramlage, W Dieter Paar, Martin Thoenes, Thomas Unger Cardiovascular Diabetology 2007, 6:12 (3 April 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

31.

10893
Accesses

Original investigation   Open Access

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

Adam R Baker, Nancy F da Silva, David W Quinn, Alison L Harte, Domenico Pagano, Robert S Bonser, Sudhesh Kumar, Philip G McTernan Cardiovascular Diabetology 2006, 5:1 (13 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

32.

10817
Accesses

Original investigation   Open Access

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

Carlos A Aguilar-Salinas, Andréia Assis-Luores-Vale, Benjamín Stockins, Hector Rengifo, José Filho, Abrahão Neto, Lísia Rabelo, Kerginaldo Torres, José Oliveira, Carlos Machado, Eliana Reyes, Victor Saavedra, Fernando Florenzano, Ma Hernández, Sergio Jiménez, Erika Ramírez, Cuauhtémoc Vazquez, Saul Salinas, Ismael Hernández, Octavio Medel, Ricardo Moreno, Paula Lugo, Ricardo Alvarado, Roopa Mehta, Victor Gutierrez, Francisco J Gómez Pérez Cardiovascular Diabetology 2004, 3:8 (23 July 2004)

Abstract | Full text | PDF | PubMed | 1 comment

33.

10806
Accesses

Original investigation   Open Access Highly Accessed

Low serum amylase in association with metabolic syndrome and diabetes: A community-based study

Kei Nakajima, Tohru Nemoto, Toshitaka Muneyuki, Masafumi Kakei, Hiroshi Fuchigami, Hiromi Munakata Cardiovascular Diabetology 2011, 10:34 (17 April 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

34.

10605
Accesses

Review   Open Access Highly Accessed

Renal protection in diabetes: lessons from ONTARGET®

Eberhard Ritz, Roland E Schmieder, Carol A Pollock Cardiovascular Diabetology 2010, 9:60 (1 October 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

35.

10525
Accesses

Review   Open Access Highly Accessed

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes

Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands, Andries Smit Cardiovascular Diabetology 2008, 7:29 (7 October 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

36.

10522
Accesses

Review   Open Access Highly Accessed

A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease

Enrique Z Fisman, Alexander Tenenbaum Cardiovascular Diabetology 2009, 8:38 (20 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

37.

10317
Accesses

Original investigation   Open Access Highly Accessed

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya Cardiovascular Diabetology 2012, 11:92 (6 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

38.

10315
Accesses

Original investigation   Open Access

Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus

Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro, Joseph Shemesh Cardiovascular Diabetology 2003, 2:14 (23 November 2003)

Abstract | Full text | PDF | PubMed

39.

10296
Accesses

Review   Open Access Highly Accessed

Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors

L Romayne Kurukulasuriya, James R Sowers Cardiovascular Diabetology 2010, 9:45 (30 August 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

40.

10239
Accesses

Original investigation   Open Access Highly Accessed

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle Cardiovascular Diabetology 2012, 11:3 (10 January 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

41.

10162
Accesses

Review   Open Access Highly Accessed

What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

Samir G Mallat Cardiovascular Diabetology 2012, 11:32 (10 April 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

42.

10023
Accesses

Editorial   Open Access Highly Accessed

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

Alexander Tenenbaum, Enrique Z Fisman Cardiovascular Diabetology 2004, 3:10 (1 December 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

43.

9841
Accesses

Original investigation   Open Access

Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects

Radka Lichnovská, Simona Gwozdziewiczová, Jirí Hrebícek Cardiovascular Diabetology 2002, 1:4 (14 October 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

44.

9709
Accesses

Original investigation   Open Access Highly Accessed

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone, Pietro Fratino Cardiovascular Diabetology 2002, 1:5 (22 November 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

45.

9469
Accesses

Original investigation   Open Access

Silent myocardial infarction in women with impaired glucose tolerance: The Northern Sweden MONICA study

Dan Lundblad, Mats Eliasson Cardiovascular Diabetology 2003, 2:9 (21 August 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

46.

9194
Accesses

Original investigation   Open Access Highly Accessed

Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl-Heinz Jöckel, Susanne Moebus Cardiovascular Diabetology 2008, 7:31 (15 October 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

47.

9101
Accesses

Original investigation   Open Access Highly Accessed

Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records

Noboru Kitamura, Yasuo Takahashi, Shuukoh Yamadate, Satoshi Asai Cardiovascular Diabetology 2007, 6:26 (29 September 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

48.

8995
Accesses

Original investigation   Open Access Highly Accessed

A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program

Sabine Frisch, Armin Zittermann, Heiner K Berthold, Christian Götting, Joachim Kuhn, Knut Kleesiek, Peter Stehle, Heinrich Körtke Cardiovascular Diabetology 2009, 8:36 (18 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

49.

8990
Accesses

Original investigation   Open Access

Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

Wenlan Duan, Latha Paka, Sivaram Pillarisetti Cardiovascular Diabetology 2005, 4:16 (5 October 2005)

Abstract | Full text | PDF | PubMed

50.

8902
Accesses

Original investigation   Open Access

Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial

Klaus Empen, Robert JA Frost, H Geiss, Carsten Otto, Klaus G Parhofer Cardiovascular Diabetology 2003, 2:17 (8 December 2003)

Abstract | Full text | PDF | PubMed

Page 2 of 4

 Previous 1 2 3 4  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.